Duration of Coverage : Some policies might cover short-term medication trials, while others may offer long-term support
This registry is collecting information about the safety of antiepileptic drugs during pregnancy
There are no hidden / additional fees for follow up visits
The European Medicines Agencys 2025 synthetic peptide quality guideline treats peptide-related impurities as first-class critical quality attributes: deletion and truncated sequences, dimers, oligomers, and degradation products each need characterization, with European Pharmacopoeia practice pointing to reporting thresholds at 0.1% and identification thresholds above 0.5% for peptide-related impurities in pharmaceutical use
Following an update to its Summary of Product Characteristics (SmPC) in April 2026, the MHRA now indicates that Mounjaro (tirzepatide) could be considered for use during breastfeeding a notable shift from earlier caution
RETA improved glucose tolerance compared to baseline tolerance tests at the start of the study, as well as compared to Veh at study midpoint (Supplementary Figs
